FCGR3A and glioblastoma: In the analysis of progression-free survival (PFS), FCGR3A was an independent risk prognostic factor in GBM (p = 0.023, HR = 1.199), KIRC (p = 0.022, HR = 1.173), LGG (p < 0.001, HR = 1.274), PRAD (p < 0.001, HR = 1.